Carmella Van de Ven (Carmella van de Ven)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 2

Top Topics

Hodgkin Lymphoma

Multiple Myeloma

Top Venues

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Aliza Gardenswartz, Brinda Mehta, Nader Kim El-Mallawany, Carmella Van de Ven, Jessica Hochberg, Allyson Flower, Erin Morris, Lauren Harrison, Yaya Chu, Jaclyn Basso, Perry Gerard, Humayun Islam, Janet Ayello, Lee Ann Baxter-Lowe, Mitchell S Cairo
Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma. Leukemia & lymphoma (2022)
Yaya Chu, Sanghoon Lee, Tishi Shah, Changhong Yin, Matthew Barth, Rodney R Miles, Janet Ayello, Erin Morris, Lauren Harrison, Carmella Van de Ven, Paul J Galardy, Stanton C Goldman, Megan S Lim, Michelle Hermiston, Linda M McAllister-Lucas, Lisa Giulino-Roth, Sherrie L Perkins, Mitchell S Cairo
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model. Oncoimmunology 8 (1) (2018)